epidermal-growth-factor has been researched along with Coronavirus-Infections* in 3 studies
1 trial(s) available for epidermal-growth-factor and Coronavirus-Infections
Article | Year |
---|---|
Effects of epidermal growth factor on atrophic enteritis in piglets induced by experimental porcine epidemic diarrhoea virus.
Epidermal growth factor (EGF) promotes gastrointestinal mucosal recovery by stimulating the mitogenic activity of intestinal crypt epithelial cells. The aim of this study was to determine the effects of EGF on atrophic enteritis induced in piglets by experimental infection with porcine epidemic diarrhoea virus (PEDV) strain Dr13. Two groups of 12 conventional, colostrum-deprived, 1-day-old, large White-Duroc cross breed piglets were inoculated orally with PEDV (3 x 10(5) 50% tissue culture infective doses), with or without EGF (10 microg/kg/day, intraperitoneally once daily for 4 days after infection) and compared to 12 uninfected, untreated control piglets. PEDV+EGF piglets had less severe clinical signs than PEDV only piglets at 48 and 60 h post-infection (hpi). Histologically, the ratio of villous height:crypt depth of PEDV+EGF piglets was significantly higher than PEDV only piglets at 36 and 48 hpi. Immunohistochemistry for Ki67 demonstrated increased proliferation in intestinal crypt epithelial cells of PEDV+EGF piglets compared to PEDV only piglets at 36, 48 and 60 hpi. EGF stimulates proliferation of intestinal crypt epithelial cells and promotes recovery from atrophic enteritis in PEDV-infected piglets. Topics: Animals; Coronavirus Infections; Enteritis; Epidermal Growth Factor; Immunohistochemistry; Jejunum; Ki-67 Antigen; Porcine epidemic diarrhea virus; Recombinant Proteins; Swine | 2008 |
2 other study(ies) available for epidermal-growth-factor and Coronavirus-Infections
Article | Year |
---|---|
Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Epidermal Growth Factor; Estrogens; Female; Humans; Lung; Male; Nasal Mucosa; Pandemics; Pneumonia, Viral; Progesterone; Risk; SARS-CoV-2; Virulence | 2020 |
Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity.
Despite the ongoing spread of MERS, there is limited knowledge of the factors affecting its severity and outcomes. We analyzed clinical data and specimens from fourteen MERS patients treated in a hospital who collectively represent a wide spectrum of disease severity, ranging from mild febrile illness to fatal pneumonia, and classified the patients into four groups based on severity and mortality. Comparative and kinetic analyses revealed that high viral loads, weak antibody responses, and lymphopenia accompanying thrombocytopenia were associated with disease mortality, whereas persistent and gradual increases in lymphocyte responses might be required for effective immunity against MERS-CoV infection. Leukocytosis, primarily due to increased neutrophils and monocytes, was generally observed in more severe and fatal cases. The blood levels of cytokines such as IL-10, IL-15, TGF-β, and EGF were either positively or negatively correlated with disease mortality. Robust induction of various chemokines with differential kinetics was more prominent in patients that recovered from pneumonia than in patients with mild febrile illness or deceased patients. The correlation of the virological and immunological responses with disease severity and mortality, as well as their responses to current antiviral therapy, may have prognostic significance during the early phase of MERS. Topics: Adult; Aged; Aged, 80 and over; Coronavirus Infections; Cytokines; Epidermal Growth Factor; Female; Humans; Kinetics; Leukocytosis; Lymphopenia; Male; Middle Aged; Middle East Respiratory Syndrome Coronavirus; Pneumonia; Severity of Illness Index; Thrombocytopenia; Viral Load; Virus Shedding | 2016 |